Bio-Tech innovation
|
We have a institute of R & D, focus on fermentation technology innovation, including optimizing of strain and process,product quality improving, cost cut, etc. --our abamectin with higher ratio of abamectin B1a:B1b up to 90:1, some between 400 and 500, meaning higher efficacy of the product. --our spinosad with higher ratio of spinsyn A : spinosyn D up to 6:1 and higher assay up to 96%, meaning higher efficacy of the product. |
|
|
|
Qilu Inner Mongolia has been rewarded second prize of national science and technology progress for abamectin high efficient biological synthesis and manufacture. |
|
Qilu Inner Mongolia has successfully developed and commercialized spinosad in 2017. One Aug. 17, spinosad has been produced in Qilu Pharmaceutical hulun buir branch, total capacity of 1500 mt, as make Qilu Inner Mongolia be the biggest manufacturer of spinosad world wide. Hi-Tech enterprise Centre of fermentation engineering technology for biopesticide and veterinary API and centre of enterprise technology innovation of inner mongolia autonomous region. National Postdoctoral workstation. |
|
Contact us
Tel: 86-471-3260020
E-mail: xueyin.xia@qilu-pharma.com
Address: No. 2 Weisi Road, Jinchuanan District, Economy & Technology Development Zone, Hohhot City, Inner Mongolia, China
Messages


